Orange City Main Site
Our main clinical trial site anchors research operations for Central Florida. Outpatient study visits across endocrinology, pulmonology, psychiatry, and internal medicine run here, supported by an in-house regulatory department and a certified sample-processing laboratory.
What happens here
- 4 treatment rooms and 5 examination rooms
- Full-service on-site regulatory department
- Certified sample-processing lab (refrigerated centrifuges, −70°C and −20°C storage)
- On-site pharmacy with laminar flow hood for investigational product
- Bilingual English / Spanish study team
Studies enrolling at this location
Type 2 Diabetes with Obesity
Evaluating a new investigational therapy for adults with Type 2 Diabetes and obesity, measuring weight loss, metabolic health, and glycemic control.
See study →COPD with Type 2 Inflammation
Testing Depemokimab, an investigational long-acting anti-IL-5 therapy, to reduce exacerbations in adults with moderate-to-severe COPD.
See study →Idiopathic Short Stature (ISS) Growth Study
Evaluating Vosoritide, an investigational therapy designed to support bone growth and improve height outcomes in children with Idiopathic Short Stature.
See study →Major Depressive Disorder: Relapse Prevention
Testing Brenipatide alongside standard antidepressant therapy to delay or prevent relapse in adults currently in remission from MDD.
See study →Adults Living with Obesity (Without Diabetes)
Clinical research evaluating weight management for adults living with obesity who do not have a diabetes diagnosis.
See study →Type 2 Diabetes with Overweight or Obesity (VESPER-5)
A Phase 3 study (VESPER-5) of an investigational ultra-long-acting GLP-1 receptor agonist for adults with overweight or obesity and Type 2 Diabetes.
See study →Type 2 Diabetes with Obesity (AMAZE 8)
An investigational treatment study (AMAZE 8) for adults living with Type 2 Diabetes and overweight or obesity.
See study →Tardive Dyskinesia
A clinical research study of an investigational treatment for adults with tardive dyskinesia, involuntary, repetitive movements often linked to long-term use of certain psychiatric medications.
See study →Tardive Dyskinesia: Valbenazine Study
A Phase 4, open-label study of valbenazine for adults with tardive dyskinesia who remain symptomatic on deutetrabenazine or after stopping a prior VMAT2 inhibitor.
See study →Getting here
2541 South Volusia Ave., Suite 100, Orange City, FL 32763. Open in Maps ↗
Every study at this location runs under independent IRB oversight and ICH Good Clinical Practice standards.